SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Fresenius Kabi Oncology

Fresenius Kabi Oncology

BSE: 532545 | NSE: FKONCO | ISIN: INE575G01010 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio

Fresenius Kabi is not traded on BSE in the last 30 days

Fresenius Kabi is not traded on NSE in the last 30 days

MARKET CAP (Rs Cr)
0.00
*P/E
0.00
*BOOK VALUE (Rs)
42.55
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
24.40
*EPS (TTM)
-
*P/C
0.00
*PRICE/BOOK
-
DIV YIELD.(%)
-%
FACE VALUE (Rs)
1.00
DELIVERABLES (%)
new
* Based on standalone numbers
Track Fresenius Kabi on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

17 October 2014

sell

HDFC Oct Fut

Entry Price (Rs)

996.00

Exit Price (Rs)

981.00

Gain (Rs)

15.00

buy

MM Oct Fut

Entry Price (Rs)

1,246.00

Exit Price (Rs)

1,259.50

Gain (Rs)

14.00

buy

ITC Oct Fut

Entry Price (Rs)

353.50

Exit Price (Rs)

361.00

Gain (Rs)

7.00

buy

Mcleod Oct Fut

Entry Price (Rs)

253.75

Exit Price (Rs)

259.00

Gain (Rs)

5.00

buy

ZeeEntertain Oct Fut

Entry Price (Rs)

327.40

Exit Price (Rs)

332.00

Gain (Rs)

5.00

buy

TitanCompany Oct Fut

Entry Price (Rs)

374.30

Exit Price (Rs)

377.90

Gain (Rs)

4.00

buy

REC Oct Fut

Entry Price (Rs)

250.25

Exit Price (Rs)

252.80

Gain (Rs)

3.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 126.00 132.00  
High Price 126.10 132.60  
Low Price 123.40 132.00  
Last Price 125.90 N.A -100.00
Volume 15,228 91,518 500.99
Simple Moving Averages
Days BSE NSE
30
50
150
200

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Fresenius Kabi

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Standalone (Dec '13)
(Sep '13)
Net Sales 45.27 81.56
Other Income 6.20 0.00
PBDIT -30.52 -28.88
Net Profit -63.63 -44.79

Annual Report

Download in PDF format 2013 |2012 |2011 |2010
Balance Sheet
(Sep '13)
(In Rs Cr)
Total Share Capital 15.82
Net Worth 673.18
Total Debt 140.16
Net Block 351.74
Investments 0.03
Net Current Assets 298.50
Total Assets 813.34
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 811.40 1.70 877.40 583.70 168,054.24
Lupin 1352.80 0.71 1442.30 858.20 60,730.74
Dr Reddys Labs 2982.45 1.98 3353.85 2420.00 50,810.76
Cipla 608.50 2.42 639.05 368.70 48,857.76
Cadila Health 1341.00 1.22 1373.20 660.95 27,456.78
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 13Jun' 13Mar' 13Dec' 12
Promoter81.0081.0081.0081.00
FII9.478.658.088.00
DII1.451.261.241.26
Others8.089.099.689.74
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
B - 310, Som Datt Chambers - I,,Bhikaji Cama Place
City
New Delhi
State
Delhi
Pin Code
110066
Tel. No.
011-26105570
Fax No.
011-26195965
REGISTRARS
Name
M C S Ltd.
Address
F-65, Okhla Industrial Area Phase-1,
City
New Delhi - 110020
State
Delhi
Tel. No.
011-41406149, 41406151,41406152
Fax No.
011-41709881
MANAGEMENT
Name
Designation
Rakesh Bhargava
Non Executive Chairman
Peter F Nilsson
Managing Director & CEO
Dilip G Shah
Ind. Non-Executive Director
Michael Schonhofen
Non Executive Director
Gerrit Steen
Non Executive Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Visaka Industries Recommended on Jun 16th 2014

Recommended price 101.00  |  Peak from reco 143.00 41.03%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Fresenius Kabi

Fresenius Kabi is in the Pharmaceuticals sector. The company has reported a standalone sales of Rs 45.27 crore and a Net Loss of Rs -63.63 crore for the quarter ended Dec 2013.

The company management includes Rakesh Bhargava - Non Executive Chairman, Peter F Nilsson - Managing Director & CEO, Dilip G Shah - Ind. Non-Executive Director, Michael Schonhofen - Non Executive Director, Gerrit Steen - Non Executive Director, Naresh Trehan - Ind. Non-Executive Director, Rajiv Lochan Jain - Independent Director.

It is listed on the BSE with a BSE Code of 532545 and the NSE with an NSE Code of FKONCO.

Its Registered office is at B - 310, Som Datt Chambers - I,,Bhikaji Cama Place New Delhi,Delhi - 110066.

Their Registrars are M C S Ltd.

Quick Links for Fresenius Kabi Oncology
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Fresenius Kabi